Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive 
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China 
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers 
Netflix Plans All-Cash Bid for Warner Bros Discovery Studios Amid Intense Hollywood Takeover Battle 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
LAKE FOREST, Calif., April 06, 2017 -- InMode Aesthetic Solutions®, a leader in aesthetic medicine and technology, is proud to announce the launch of the brand’s newest procedure, BodyTite. This non-excisional device utilizes radio-frequency assisted lipolysis (RFAL) to address the shortcomings often associated with traditional liposuction or surgical body and face lifts, including sagging or wrinkly skin and scarring, by inserting a wand under the skin to coagulate inside while tightening the skin on top.
With over one hundred surgical practices in North America already utilizing the new technology, doctors can ensure their patients receive surgical-like procedures with limited downtime and without scars. The FDA approved technology, for use on the stomach, arms, chest, knees and inner/outer thighs, is minimally invasive and leaves virtually no scarring. Results can be seen immediately after one treatment and are more evident over three to six months post-treatment.
Previously, patients looking for fat reduction treatments had limited options including multiple non-invasive treatments with limited skin contraction results, a surgical tummy tuck with downtime or a brachioplasty, leaving large excision scars. These options left patients who wanted less invasive procedures without a solution, or unhappy with the results of their treatment. With BodyTite, doctors are able to ensure patients receive minimally invasive, effective procedures and offer powerful aesthetic results.
“Traditional surgery can leave permanent scars, and does not really fix the problem -- soft tissue with no internal support framework,” Diane Duncan, M.D., Fort Collins CO, a practitioner of BodyTite explains. “This new device is providing that internal structure reorganization, and in addition, has been proven to create up to 36.4% skin surface area contraction at one year” (Duncan, Aesthetic Surgery Journal, 2016).
“BodyTite is one of many technological innovations to come from InMode this year,” says Erik Dowell, CEO of InMode North America. “With our enhanced management team, we are looking forward to showcasing the advances we are making to the cosmetic industry to doctors and patients alike.”
About InMode: InMode’s technological advancements have become the new standard for aesthetic medicine, specifically in the radio-frequency aesthetic market. For more than three decades our R&D team was critical in developing state-of-the-art light, laser and radio-frequency devices, thereby launching and shaping the industry. Our technology continues that legacy in providing superior satisfaction for both the patient and the practice. Learn more about InMode technologies by visiting www.inmodemd.com.
Press Contact: Gianna Visconti | The Woods & Co [email protected] | 212.838.1878
